SCHEMBL23768639

SCHEMBL23768639

CCCCCCCCCCCCCCOCC(COC=O)OCCCCCCCCCCCCCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LPAR1 Q92633 4/20 0.58
▸ LPAR3 Q9UBY5 4/20 0.58
▸ LPAR2 Q9HBW0 1/20 0.54
▸ TLR2 O60603 7/20 0.47
▸ DNM1 Q05193 1/20 0.46
▸ USP2 O75604 1/20 0.43
▸ HTT P42858 1/20 0.42
▸ PRKD3 O94806 1/20 0.41
▸ PRKCG P05129 1/20 0.41
▸ PRKCB P05771 1/20 0.41
▸ PRKCA P17252 1/20 0.41
▸ PRKCH P24723 1/20 0.41
▸ PRKCI P41743 1/20 0.41
▸ PRKCE Q02156 1/20 0.41
▸ PRKCQ Q04759 1/20 0.41
▸ PRKCZ Q05513 1/20 0.41
▸ PRKCD Q05655 1/20 0.41
▸ PRKD1 Q15139 1/20 0.41
▸ PLA2G2A P14555 3/20 0.41
▸ PLA2G10 O15496 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24710768 0.89 ALDH1A1 (0.57) LPAR1LPAR3
SCHEMBL4879843 0.85 LPAR1 (0.68) LPAR1LPAR3LPAR2TLR2DNM1
SCHEMBL30910033 0.85 LPAR1 (0.68) LPAR1LPAR3LPAR2TLR2DNM1
SCHEMBL30510651 0.85 LPAR1 (0.68) LPAR1LPAR3LPAR2TLR2DNM1
SCHEMBL8636551 0.85 LPAR1 (0.68) LPAR1LPAR3LPAR2TLR2DNM1
SCHEMBL4204833 0.85 LPAR1 (0.68) LPAR1LPAR3LPAR2TLR2DNM1
SCHEMBL7563995 0.85 LPAR1 (0.68) LPAR1LPAR3LPAR2TLR2DNM1
SCHEMBL303128 0.85 LPAR1 (0.68) LPAR1LPAR3LPAR2TLR2DNM1
SCHEMBL4294185 0.85 LPAR1 (0.68) LPAR1LPAR3LPAR2TLR2DNM1
SCHEMBL30510614 0.85 LPAR1 (0.68) LPAR1LPAR3LPAR2TLR2DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3623361-B1 LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS NOVARTIS AG (CH) 2021-08-18 — — EP disclosed
Send feedback